Home › Drug Codes › Q Codes › Q0237 · Avtozma
Updated July 1st, 2026

Avtozma Q Code: Q0237

Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for Q0237, effective October 1, 2026: $4.92 per HCPCS billing unit, unchanged from Q3 2026. From CMS's final file.

?
Medicare Payment Limit ?
$4.92
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
3
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
HCPCS Added Date January 24, 2025
Manufacturer Celltrion USA
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About Avtozma

Avtozma is a medication aligned to the HCPCS Q Code: Q0237 for billing, pricing, and reimbursement purposes in the United States. It is a COVID-19 drug administered via the intravenous route and manufactured by Celltrion USA.

Manufacturers, reach out to us to add more information.

NDC Code Information

3 NDC packages are crosswalked to Q0237. Package detail is available to logged-in subscribers.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
•••••-••••-•• Log in to view Avtozma
Avtozma
Avtozma
Login to view 3 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Avtozma Pricing & Reimbursement

Q0237 Private Payer Reimbursement
$4.26 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Tocilizumab Biosimilar Information:

Avtozma Approval Date: January 24, 2025

Product Name HCPCS Code Active Ingredient BLA Type
Actemra J3262 Tocilizumab 351(a) Originator Product
Tofidence Q0234 Tocilizumab 351(k) Biosimilar
Tofidence Q5133 Tocilizumab 351(k) Biosimilar
Tyenne Q0238 Tocilizumab 351(k) Biosimilar
Tyenne Q5135 Tocilizumab 351(k) Biosimilar
Avtozma Q0237 Tocilizumab 351(k) Interchangeable
Avtozma Q5156 Tocilizumab 351(k) Interchangeable

Avtozma CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Avtozma Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Coronavirus Disease 2019 (COVID-19) Cytokine Release Syndrome Giant Cell Arteritis Polyarticular Juvenile Idiopathic Arthritis Rheumatoid Arthritis Systemic Juvenile Idiopathic Arthritis
Drug Class
Interleukin 6 Receptor Antagonists [MoA]Interleukin-6 Receptor Antagonist [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Avtozma billing and coding guide?
Billing and coding information for Avtozma can be found through CELLTRION USA. Visit Here →
Are there any available Avtozma patient assistance programs?
Avtozma patient assistance information can be found through CELLTRION USA. Visit Here →
Where can I find Avtozma prescribing information?
Avtozma prescribing information can be found at the link below. Visit Here →
Where can I find Avtozma side effect information?
Information regarding Avtozma's side effects can be found at MedlinePlus. Visit Here →
Does billing Avtozma require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to Avtozma.

Q0234TofidenceInjection, tocilizumab-bavi, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mgBiogenAdded July 1, 2026J3262ACTEMRAInjection, tocilizumab, 1 mgMultiple ManufacturersAdded January 1, 2011Q5133TOFIDENCEInjection, tocilizumab-bavi (tofidence), biosimilar, 1 mgBiogenAdded April 1, 2024Q5156AVTOZMAInjection, tocilizumab-anoh (avtozma), biosimilar, 1 mgMultiple ManufacturersAdded October 1, 2025Q0249ACTEMRAInjection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mgMultiple ManufacturersAdded June 24, 2021Q0238TyenneInjection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mgFresenius KabiAdded April 1, 2026Q5135TYENNEInjection, tocilizumab-aazg (tyenne), biosimilar, 1 mgMultiple ManufacturersAdded October 1, 2024J0129ORENCIAInjection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)BMSAdded January 1, 2007J0717CIMZIAInjection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)UCB PharmaAdded January 1, 2014J1438ENBRELInjection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)AmgenAdded January 1, 2000